Medicare Enrolled
Dr. Robert Carney, MD
Cardiovascular Disease · Tyler, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carney? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carney
Dr. Robert Carney is a cardiovascular disease in Tyler, TX, with 20 years in practice. Based on federal Medicare data, Dr. Carney performed 6,151 Medicare services across 3,142 unique beneficiaries.
Between the years covered by Open Payments, Dr. Carney received a total of $10,738 from 41 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 11% volume in TX$ $10,738 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,151
Medicare services
Top 11% in TX for cardiovascular disease
3,142
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,507 | $0 | $3 |
| Office visit, established patient (30-39 min) | 1,131 | $88 | $238 |
| Office visit, established patient (20-29 min) | 569 | $60 | $160 |
| Chronic care management, first 20 min/month | 504 | $44 | $125 |
| EKG interpretation and report | 453 | $6 | $50 |
| Electrocardiogram (EKG), 12-lead | 214 | $10 | $100 |
| Chronic care management, additional 20 min/month | 188 | $33 | $63 |
| New patient office visit (45-59 min) | 177 | $113 | $365 |
| Prothrombin time test (blood clotting) | 166 | $4 | $35 |
| Blood draw (venipuncture) | 161 | $8 | $20 |
| Anticoagulant management of patient taking warfarin | 134 | $7 | $35 |
| Remote pacemaker monitoring, 90 days | 116 | $20 | $92 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 106 | $17 | $107 |
| Echocardiogram, transthoracic | 89 | $52 | $306 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 88 | $59 | $394 |
| Programming of dual lead pacemaker system | 75 | $26 | $120 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 71 | $6 | $188 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $11 | $167 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 34 | $50 | $135 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $26 | $132 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | $39 | $880 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 26 | $17 | $167 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 26 | $44 | $358 |
| Evaluation of heart function using tilt table | 25 | $68 | $263 |
| Injection of x-ray contrast during ultrasound of heart | 24 | $23 | $88 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $5 | $51 |
| Cardiac catheterization | 22 | $790 | $14,500 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $89 | $268 |
| Heart muscle strain imaging | 18 | $9 | $94 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $81 | $362 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $2 | $35 |
| Coronary stent placement | 14 | $403 | $1,790 |
| Ultrasound of heart, follow-up | 14 | $18 | $132 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $232 | $1,053 |
| Transitional care management services for problem of at least moderate complexity | 12 | $151 | $282 |
| Initial hospital admission, high complexity | 11 | $135 | $457 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.4% high complexity
28.5% medium
65.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,738
Total received (2018-2024)
Avg $1,534/year across 7 years
Top 30% in TX for cardiovascular disease
41
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,738 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,321
2023$1,276
2022$1,514
2021$1,624
2020$778
2019$1,849
2018$2,376
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,083
AstraZeneca Pharmaceuticals LP
$970
E.R. Squibb & Sons, L.L.C.
$925
Janssen Pharmaceuticals, Inc
$836
Amgen Inc.
$792
PFIZER INC.
$758
Merck Sharp & Dohme LLC
$633
Medtronic, Inc.
$587
Abbott Laboratories
$410
SANOFI-AVENTIS U.S. LLC
$359
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$340
Medtronic Vascular, Inc.
$230
CVRx, Inc.
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Alnylam Pharmaceuticals Inc.
$153
Amarin Pharma Inc.
$128
Boston Scientific Corporation
$127
Gilead Sciences, Inc.
$104
Merck Sharp & Dohme Corporation
$82
Novo Nordisk Inc
$80
ABIOMED
$80
Bayer HealthCare Pharmaceuticals Inc.
$76
Esperion Therapeutics, Inc.
$63
Lundbeck LLC
$59
Regeneron Healthcare Solutions, Inc.
$53
Lexicon Pharmaceuticals, Inc.
$47
Philips Electronics North America Corporation
$41
AltaThera Pharmaceuticals LLC
$37
ShockWave Medical, Inc
$31
Kowa Pharmaceuticals America, Inc.
$31
ARBOR PHARMACEUTICALS, INC.
$29
BOSTON SCIENTIFIC CORPORATION
$29
BIOTRONIK INC.
$27
iRhythm Technologies, Inc.
$24
Vifor Pharma, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$23
Kiniksa Pharmaceuticals, Ltd.
$17
Tactile Systems Technology Inc
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$14
Otsuka America Pharmaceutical, Inc.
$14
Surmodics, Inc.
$13
Top 3 companies account for 37.1% of total payments
Associated products mentioned in payments ›
(5044) MCOT · 3F · Acticor 7 VR-T DX · Arcalyst · Asahi Fielder XT cornary guide wire · Asahi Fielder coronary guide wire · Asahi Sion guide wire · Assurity Pacemaker · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · EUPHORA · Edarbi · FARXIGA · Flexitouch Plus · General - Atherectomy · General - Therapies · Hi-Torque Whisper guide wire · ICDs · IN.PACT Admiral · INVOKANA · Impella · IntraStent · JARDIANCE · Kerendia · LEQVIO · LIBTAYO · LOKELMA · LifeVest · Livalo · MULTAQ · Mini Trek catheters · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · ONYX FRONTIER · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Perclose ProGlide suture mediated closure system · RESOLUTE ONYX · RESONATE · Repatha · Resolute · Reveal LINQ · Rybelsus · SAMSCA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Sotalol Hydrochloride · Sublime 014 Rx PTA Balloon Dilatation Catheter · TELESCOPE · Telescope · TrailBlazer · TurboHawk · VERQUVO · Vascepa · Veltassa · Verquvo · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $175 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
29
Per 100K population
12.2
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Carney is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Carney experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Carney performed 1,507 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carney receive payments from pharmaceutical companies?
Yes. Dr. Carney received a total of $10,738 from 41 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carney's costs compare to other cardiovascular diseases in Tyler?
Dr. Carney's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Tyler
Browse cardiovascular diseases in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology